Curcumin nanogel versus steroid paste for erosive oral lichen planus
Compares curcumin nanogel with steroid paste for oral lichen planus.
Key facts
- Who runs it
- Chulalongkorn University
- Where
- Thailand1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% FAO in the Management of Oral Lichen Planus
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 1 Jun 2025
- Planned end
- 30 Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Curcumin in Nanogels
- 0.1% Fluocinolone Acetonide Oral Paste
- Record updated
- 6 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with painful erosive or atrophic oral lichen planus, an inflammatory condition inside the mouth. It compares curcumin nanogel with 0.1% fluocinolone acetonide oral paste.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Erosive or atrophic oral lichen planus, confirmed by exam and tissue sample, with some pain (NRS pain score > 0).
- Earlier treatment
- No topical or systemic treatment for oral lichen planus in the past 2 weeks. No current immunosuppressants.
Main reasons for not taking part
- Pregnancy or breastfeeding
- Uncontrolled diabetes (HbA1c > 7% (53 mmol/mol) or FPG > 130 mg/dL (7.2 mmol/L))
- Use of blood thinners or antiplatelet drugs
- Active cancer or infection, or past stomach or duodenal ulcers or gallstones
- Current smokers, or allergy to corticosteroids or herbal agents such as turmeric
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Age 18 years or older
- Ability to provide written informed consent
- Clinically and histopathologically confirmed diagnosis of erosive or atrophic oral lichen planus (OLP)
- Presence of symptoms (NRS pain score > 0 at baseline)
- Ability to communicate and follow instructions
- Willingness to apply oral paste treatment and comply with study protocol
Who cannot take part
- History of gastric ulcers, duodenal ulcers, or gallstones
- Presence of any active malignancy or infection
- Known allergy to corticosteroids or herbal agents such as turmeric
- Diagnosis of oral lichenoid contact lesion or graft-versus-host disease (GVHD)
- History of allogeneic bone marrow transplantation
- Uncontrolled diabetes mellitus (HbA1c > 7% or FPG > 130 mg/dL)
- Pregnancy or lactation
- Current orthodontic treatment
- Use of anticoagulants or antiplatelet agents
- Severe dry mouth (Challacombe score > 7)
- Use of topical/systemic treatment for OLP in the past 2 weeks
- Current use of immunosuppressants
- Current smokers
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized, double-blind clinical trial evaluates the therapeutic effects of curcumin in nanogels compared to 0.1% fluocinolone acetonide oral paste in the management of atrophic-erosive oral lichen planus (OLP). The study aims to determine whether curcumin nanogels, a natural treatment with enhanced bioavailability, are as effective and better tolerated than standard corticosteroid therapy.
The 2 groups in the trial
- Curcumin GroupTreatment being tested
Curcumin nanogels applied 3 times daily for 4 weeks
Treatment: Curcumin in Nanogels
- Fluocinolone Paste GroupExisting treatment, for comparison
0.1% Fluocinolone acetonide oral paste applied 3 times daily for 4 weeks
Treatment: 0.1% Fluocinolone Acetonide Oral Paste
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% Fluocinolone Acetonide Oral Paste in the Management of Atrophic-Erosive Oral Lichen Planus
- Plain-language title
- Curcumin nanogel versus steroid paste for erosive oral lichen planusGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 6 March 2026